Circumference Reduction Clinical Trial
Official title:
Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction
Prospective, one-arm, baseline-controlled pilot study for the evaluation of the VelaShape III combined with UltraShape Power treatment for non-invasive circumference reduction to the thighs.
Eligible subjects will receive 3 bi-weekly treatments to the thighs at 2-week intervals, with
the VelaShape III and UltraShape Power devices according to the study protocol.
Each subject will return for 3 follow up visits: four weeks (4wk FU), 8 weeks (8wk FU) and 12
weeks (12wk FU) after the last treatment (Tx.3), for total expected study duration of 16
weeks.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02109107 -
Study of Low Level Laser Light Therapy on Circumference Reduction
|
N/A | |
| Terminated |
NCT01026441 -
Clinical Study to Evaluate the Safety and Efficacy of the Vela100
|
Phase 4 | |
| Completed |
NCT05674292 -
An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring
|
N/A | |
| Recruiting |
NCT02956720 -
UltraShape Power in Combination With U-sculpt-n Transducer
|
N/A | |
| Terminated |
NCT02591056 -
Study of the Combined Effect of Low Level Laser Therapy and Manual Lymph Drainage on Reducing Body Circumference
|
N/A | |
| Completed |
NCT01234259 -
Evaluation of Safety and Efficacy of Using Venus Freeze™ (MP)2 V2 System for Wrinkles Rhytides and Cellulite Treatment
|
N/A |